Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  WIENER BOERSE AG  >  Sanochemia Pharmazeutika AG    SCPH   AT0000776307

SANOCHEMIA PHARMAZEUTIKA AG (SCPH)
Add to my list  
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Wiener Boerse Ag
10/12/2017 10/13/2017 10/16/2017 10/18/2017 10/20/2017 Date
1.613 1.598 1.65 1.58 1.58 Last
1500 5500 221 9000 150 Volume
-0.55% -0.93% +3.25% -4.24% 0.00% Change
Financials (€)
Sales 2017 49,2 M
EBIT 2017 1,30 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 46,5 M
EBIT 2018 1,80 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0,41x
Capi. / Sales2018 0,44x
Capitalization 20,4 M
More Financials
Company
SANOCHEMIA Pharmazeutika AG engages in the manufacture and distribution of pharmaceutical products.It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, and Research and Development.The Production segment focuses on synthesis of active... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on SANOCHEMIA PHARMAZEUTIKA A
09/11 SANOCHEMIA PHARMAZEUTIKA : Tolperisone USA
07/18 SANOCHEMIA PHARMAZEUTIKA : Advantage of tolperisone in comparison to another mus..
06/06 SANOCHEMIA PHARMAZEUTIKA : Notice of Allowance for Tolperisone in the US
05/18SANOCHEMIA PHARMAZEUTIKA AG : half-yearly earnings release
03/27 SANOCHEMIA PHARMAZEUTIKA : Participation at the ECR
01/19 SANOCHEMIA PHARMAZEUTIKA : Advancement of Tolperisone's Clinical Development in ..
01/13 SANOCHEMIA PHARMAZEUTIKA : Grant of patent for Vidon® in the USA
01/06 SANOCHEMIA PHARMAZEUTIKA : "Compositions of Tolperisone" in Patent Application A..
More news
Sector news : Specialty & Advanced Pharmaceuticals
10/21 JOHNSON & JOHNSON : California judge tosses $417 million talc cancer verdict aga..
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
More sector news : Specialty & Advanced Pharmaceuticals
Chart SANOCHEMIA PHARMAZEUTIKA A
Duration : Period :
Sanochemia Pharmazeutika A Technical Analysis Chart | SCPH | AT0000776307 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 3,00 €
Spread / Average Target 90%
Managers
NameTitle
Eveline Frantsits Chairman-Supervisory Board
Stefan Welzig Chief Financial & Technical Officer
Christina Abrahamsberg Chief Scientific Officer
Anton Dallos Member-Supervisory Board
Werner Josef Frantsits Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SANOCHEMIA PHARMAZEUTIKA AG13.75%24
ABBVIE53.37%153 193
MERCK KGAA-4.68%14 304
KYOWA HAKKO KIRIN CO LTD24.97%10 266
JAZZ PHARMACEUTICALS PLC28.83%8 652
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD33.70%5 811